Literature DB >> 20233720

Involvement of oxidative stress in the relapse of acute myeloid leukemia.

Fu-Ling Zhou1, Wang-Gang Zhang2, Yong-Chang Wei3, Shan Meng2, Gai-Gai Bai2, Bai-Yan Wang4, Hui-Yun Yang2, Wei Tian2, Xin Meng2, Hui Zhang2, She-Ping Chen2.   

Abstract

The aims of the present study were to determine the level of oxidative stress and the salient factors leading to the relapse of acute myeloid leukemia (AML). Oxidative stress-related parameters and the expressions of specific genes were monitored in 102 cases of AML during a pretreatment period from a primary status to a relapse status. In addition, age-matched healthy subjects were classified as controls. The activities of adenosine deaminase and xanthine oxidase were higher in the relapse condition, whereas those of glutathione peroxidase, monoamine oxidase, and superoxide dismutase, and the total antioxidant capacity (T-AOC) were lower in the primary condition and in controls. Of particular note, levels of advanced oxidation protein products, malondialdehyde, and 8-hydroxydeoxyguanosine were also significantly higher in relapse patients. Furthermore, real-time PCR with SYBR Green revealed that the expression levels of human thioredoxin (TRX) and indoleamine 2,3-dioxygenase were increased in relapse patients. Pearson correlation analysis revealed that the T-AOC was positively correlated with GSH but negatively correlated with 8-OHdG, TRX, and indoleamine 2,3-dioxygenase. Linear regression showed that a low T-AOC and up-regulated TRX expression were the independent factors correlated with relapse. A strong association between oxidative stress and the incidence of disease relapse was observed, which has potential prognosis implications. These results indicate that oxidative stress is a crucial feature of AML and probably affects the development and relapse of AML.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233720      PMCID: PMC2865279          DOI: 10.1074/jbc.M110.103713

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  The changes of oxidative stress and human 8-hydroxyguanine glycosylase1 gene expression in depressive patients with acute leukemia.

Authors:  Fuling Zhou; Wanggang Zhang; Yongchang Wei; Dangxia Zhou; Zhixing Su; Xin Meng; Lingyun Hui; Wei Tian
Journal:  Leuk Res       Date:  2006-09-01       Impact factor: 3.156

2.  Advanced oxidation protein products, ferrous oxidation in xylenol orange, and malondialdehyde levels in thyroid cancer.

Authors:  Funda Kosova; Bahadir Cetin; Melih Akinci; Sabahattin Aslan; Zeki Ari; Aylin Sepici; Nilgün Altan; Abdullah çetin
Journal:  Ann Surg Oncol       Date:  2007-06-13       Impact factor: 5.344

3.  Deficient proliferation and expansion in vitro of two bone marrow cell populations from patients with acute myeloid leukemia in response to hematopoietic cytokines.

Authors:  Juan José Montesinos; Elizabeth Sánchez-Valle; Eugenia Flores-Figueroa; Guadalupe Martínez-Jaramillo; Patricia Flores-Guzmán; Enrique Miranda-Peralta; Mario Gutiérrez-Romero; Hector Mayani
Journal:  Leuk Lymphoma       Date:  2006-07

4.  Measurements of oxidative stress status and antioxidant activity in chronic leukaemia patients.

Authors:  Mohammed M H Al-Gayyar; Laila A Eissa; Ahmed M Rabie; Amal M El-Gayar
Journal:  J Pharm Pharmacol       Date:  2007-03       Impact factor: 3.765

5.  Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.

Authors:  De-Yan Hou; Alexander J Muller; Madhav D Sharma; James DuHadaway; Tinku Banerjee; Maribeth Johnson; Andrew L Mellor; George C Prendergast; David H Munn
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

6.  Proinflammatory effects of advanced lipoxidation end products in monocytes.

Authors:  Narkunarajaa Shanmugam; James L Figarola; Yan Li; Piotr M Swiderski; Samual Rahbar; Rama Natarajan
Journal:  Diabetes       Date:  2007-11-14       Impact factor: 9.461

7.  Thioredoxin in human and experimental sepsis.

Authors:  Stefan Hofer; Claudia Rosenhagen; Hajime Nakamura; Junji Yodoi; Christian Bopp; Johannes B Zimmermann; Meike Goebel; Peter Schemmer; Kartrin Hoffmann; Klaus Schulze-Osthoff; Raoul Breitkreutz; Markus A Weigand
Journal:  Crit Care Med       Date:  2009-07       Impact factor: 7.598

Review 8.  Tumor immune escape mediated by indoleamine 2,3-dioxygenase.

Authors:  Maria Zamanakou; Anastasios E Germenis; Vaios Karanikas
Journal:  Immunol Lett       Date:  2007-07-02       Impact factor: 3.685

9.  Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.

Authors:  Jun Lu; Eng-Hui Chew; Arne Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

10.  Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients.

Authors:  Vanessa Battisti; Liési D K Maders; Margarete D Bagatini; Karen F Santos; Rosélia M Spanevello; Paula A Maldonado; Alice O Brulé; Maria do Carmo Araújo; Maria R C Schetinger; Vera M Morsch
Journal:  Clin Biochem       Date:  2008-02-15       Impact factor: 3.281

View more
  35 in total

1.  Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients.

Authors:  Mahmood Rasool; Shahzad Farooq; Arif Malik; Aysha Shaukat; Abdul Manan; Muhammad Asif; Suleman Sani; Mahmood Husain Qazi; Mohammad Amjad Kamal; Zafar Iqbal; Abrar Hussain
Journal:  Saudi J Biol Sci       Date:  2014-09-06       Impact factor: 4.219

2.  Jab1/Csn5-Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress.

Authors:  Fuling Zhou; Yunbao Pan; Yongchang Wei; Ronghua Zhang; Gaigai Bai; Qiuju Shen; Shan Meng; Xiao-Feng Le; Michael Andreeff; Francois X Claret
Journal:  Clin Cancer Res       Date:  2017-03-07       Impact factor: 12.531

3.  Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.

Authors:  Daniela Di Marcantonio; Esteban Martinez; Simone Sidoli; Jessica Vadaketh; Margaret Nieborowska-Skorska; Anushk Gupta; Jake M Meadows; Francesca Ferraro; Elena Masselli; Grant A Challen; Michael D Milsom; Claudia Scholl; Stefan Fröhling; Siddharth Balachandran; Tomasz Skorski; Benjamin A Garcia; Prisco Mirandola; Giuliana Gobbi; Ramiro Garzon; Marco Vitale; Stephen M Sykes
Journal:  Clin Cancer Res       Date:  2017-11-10       Impact factor: 12.531

Review 4.  Integration of hypoxic HIF-α signaling in blood cancers.

Authors:  L Schito; S Rey; M Konopleva
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

5.  Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia.

Authors:  Xin Xu; Yu Zhao; Maozhong Xu; Qiuxin Dai; Wenjun Meng; Jiangang Yang; Rujuan Qin
Journal:  Med Oncol       Date:  2010-09-02       Impact factor: 3.064

Review 6.  Oxidative stress, redox regulation and diseases of cellular differentiation.

Authors:  Zhi-Wei Ye; Jie Zhang; Danyelle M Townsend; Kenneth D Tew
Journal:  Biochim Biophys Acta       Date:  2014-11-15

7.  Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression.

Authors:  Lixin Wang; Joan S Brugge; Kevin A Janes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

8.  H2O2/Peroxynitrite-Activated Hydroxamic Acid HDAC Inhibitor Prodrugs Show Antileukemic Activities against AML Cells.

Authors:  Yi Liao; Liping Xu; Siyu Ou; Holly Edwards; Daniel Luedtke; Yubin Ge; Zhihui Qin
Journal:  ACS Med Chem Lett       Date:  2018-06-13       Impact factor: 4.345

Review 9.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

Review 10.  Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia.

Authors:  Fuling Zhou; Qiang Shen; François X Claret
Journal:  J Leukoc Biol       Date:  2013-05-28       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.